Cibus, Inc. (CBUS)
NASDAQ: CBUS · Real-Time Price · USD
1.630
+0.080 (5.16%)
Oct 27, 2025, 3:09 PM EDT - Market open
Cibus Revenue
Cibus had revenue of $933.00K in the quarter ending June 30, 2025, with 11.34% growth. This brings the company's revenue in the last twelve months to $4.85M, up 63.66% year-over-year. In the year 2024, Cibus had annual revenue of $4.26M with 134.56% growth.
Revenue (ttm)
$4.85M
Revenue Growth
+63.66%
P/S Ratio
10.15
Revenue / Employee
$30,478
Employees
159
Market Cap
88.41M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.26M | 2.45M | 134.56% |
| Dec 31, 2023 | 1.82M | 1.66M | 1,057.32% |
| Dec 31, 2022 | 157.00K | -25.83M | -99.40% |
| Dec 31, 2021 | 25.99M | 2.14M | 8.96% |
| Dec 31, 2020 | 23.85M | 16.56M | 226.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
CBUS News
- 11 days ago - Cibus and AgVayā Collaborate to Introduce Indian Rice Growers to New Solutions to Scale Crop Productivity Through Advanced Gene Editing - GlobeNewsWire
- 12 days ago - Soybean Short Squeeze: Cooking Oil Stocks Pop After Trump Targets China - Benzinga
- 25 days ago - Cibus Announces Positive Field Trial Results for Second-Generation Herbicide Tolerance (HT2) Edited Canola - GlobeNewsWire
- 4 weeks ago - Cibus Announces the Election of Kimberly A. Box to Board of Directors - GlobeNewsWire
- 5 weeks ago - Cibus CEO to Highlight Gene Editing's Role in Building Resilient Agriculture at UN Climate Week 2025 - GlobeNewsWire
- 2 months ago - Cibus Enters into Agreement with the Latin American Rice Hybrid Consortium to Provide Cibus' Herbicide Tolerance Trait - GlobeNewsWire
- 2 months ago - Cibus, Inc. (CBUS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Cibus Reports Second Quarter Financial Results and Provides Year-to-Date Business Update for 2025 - GlobeNewsWire